Clinical trials

  • PEMBROLIZUMAB for Muscle-invasive urothelial carcinoma | Urothelial carcinoma
  • Emicizumab for Hemophilia A | Hemophilia A without inhibitors
  • ETELCALCETIDE for Secondary hyperparathyroidism (secondary hyperparathyroidism, SHPT)|Chronic kidney disease on maintenance hemodialysis (Chronic kidney disease, CKD, on hemodialysis)
  • BIIB115 for Spinal muscular atrophy
  • HUMAN NORMAL IMMUNOGLOBULIN; HYALURONIDASE (HUMAN RECOMBINANT) for Primary immunodeficiency diseases
  • BAXDROSTAT for Chronic kidney disease|Hypertension
  • NUSINERSEN for Spinal Muscular Atrophy
  • Ipilimumab for Stage II melanoma
  • BAXDROSTAT for Chronic kidney disease | Hypertension
  • REMIFENTANIL HYDROCHLORIDE for Obesity | Postoperative pain
  • CROVALIMAB for Atypical hemolytic uremic syndrome (aHUS)
  • ABATACEPT for Rheumatoid arthritis